Gloria J. Klapstein

3.1k total citations · 1 hit paper
18 papers, 2.5k citations indexed

About

Gloria J. Klapstein is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Gloria J. Klapstein has authored 18 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Gloria J. Klapstein's work include Neuroscience and Neuropharmacology Research (10 papers), Receptor Mechanisms and Signaling (6 papers) and Genetic Neurodegenerative Diseases (6 papers). Gloria J. Klapstein is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Receptor Mechanisms and Signaling (6 papers) and Genetic Neurodegenerative Diseases (6 papers). Gloria J. Klapstein collaborates with scholars based in United States, Canada and Mexico. Gloria J. Klapstein's co-authors include William F. Colmers, Michael S. Levine, Carlos Cepeda, Eve S. Jokel, Marie‐Françoise Chesselet, Hadi Zanjani, Nanping Wu, Matthew S. Goldberg, Edward G. Meloni and Larry C. Ackerson and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Journal of Neurophysiology.

In The Last Decade

Gloria J. Klapstein

18 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons

2003 686 citations Matthew S. Goldberg, Sheila M. Fleming et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gloria J. Klapstein United States	15	1.9k	1.3k	960	259	219	18	2.5k
Amarbirpal Mahal United Kingdom	12	2.4k 1.2×	2.2k 1.6×	950 1.0×	214 0.8×	64 0.3×	12	3.1k
Mickaël Decressac Sweden	21	1.5k 0.8×	864 0.6×	1.3k 1.3×	418 1.6×	63 0.3×	27	2.6k
Debra A. Bergstrom United States	28	1.8k 1.0×	1.1k 0.8×	930 1.0×	131 0.5×	278 1.3×	38	2.9k
Michael Orth Germany	23	972 0.5×	857 0.6×	632 0.7×	160 0.6×	140 0.6×	36	1.6k
Anne Tscherter Switzerland	22	1.6k 0.8×	734 0.5×	1.0k 1.1×	251 1.0×	47 0.2×	38	2.3k
Damian M. Cummings United Kingdom	25	1.3k 0.7×	990 0.7×	697 0.7×	383 1.5×	59 0.3×	37	2.1k
Liliana Menalled United States	19	2.0k 1.0×	1.5k 1.1×	1.0k 1.1×	110 0.4×	44 0.2×	28	2.3k
Johannes Krupp France	24	1.4k 0.7×	1.3k 0.9×	361 0.4×	344 1.3×	44 0.2×	46	2.0k
Umar Yazdani United States	18	884 0.5×	609 0.5×	466 0.5×	514 2.0×	89 0.4×	20	1.9k
Ellen Kanter United States	12	765 0.4×	811 0.6×	666 0.7×	394 1.5×	73 0.3×	14	2.2k

Countries citing papers authored by Gloria J. Klapstein

Since Specialization

Citations

This map shows the geographic impact of Gloria J. Klapstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gloria J. Klapstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gloria J. Klapstein more than expected).

Fields of papers citing papers by Gloria J. Klapstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gloria J. Klapstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gloria J. Klapstein. The network helps show where Gloria J. Klapstein may publish in the future.

Co-authorship network of co-authors of Gloria J. Klapstein

This figure shows the co-authorship network connecting the top 25 collaborators of Gloria J. Klapstein. A scholar is included among the top collaborators of Gloria J. Klapstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gloria J. Klapstein. Gloria J. Klapstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Bhattacharya, Saveri, et al.. (2018). Fibromyalgia with Gabapentin and Osteopathic Manipulative Medicine: A Pilot Study. The Journal of Alternative and Complementary Medicine. 24(4). 395–402. 12 indexed citations

Broussard, Gerard Joey, Jennifer Mytar, Rung‐chi Li, & Gloria J. Klapstein. (2012). The role of inflammatory processes in Alzheimer’s disease. Inflammopharmacology. 20(3). 109–126. 60 indexed citations

Cepeda, Carlos, Véronique André, Jorge Flores‐Hernández, et al.. (2005). Pediatric Cortical Dysplasia: Correlations between Neuroimaging, Electrophysiology and Location of Cytomegalic Neurons and Balloon Cells and Glutamate/GABA Synaptic Circuits. Developmental Neuroscience. 27(1). 59–76. 68 indexed citations

Ariano, Marjorie A., Carlos Cepeda, Christopher R. Calvert, et al.. (2005). Striatal Potassium Channel Dysfunction in Huntington's Disease Transgenic Mice. Journal of Neurophysiology. 93(5). 2565–2574. 88 indexed citations

Klapstein, Gloria J. & Michael S. Levine. (2004). Age-Dependent Biphasic Changes in Ischemic Sensitivity in the Striatum of Huntington's Disease R6/2 Transgenic Mice. Journal of Neurophysiology. 93(2). 758–765. 10 indexed citations

Goldberg, Matthew S., Sheila M. Fleming, James Palacino, et al.. (2003). Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons. Journal of Biological Chemistry. 278(44). 43628–43635. 686 indexed citations breakdown →

Cepeda, Carlos, Raymond S Hurst, Jorge Flores‐Hernández, et al.. (2003). Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. Journal of Neuroscience Research. 72(4). 472–486. 159 indexed citations

Laforet, Genevieve, Ellen Sapp, Kathryn Chase, et al.. (2001). Changes in Cortical and Striatal Neurons Predict Behavioral and Electrophysiological Abnormalities in a Transgenic Murine Model of Huntington's Disease. Journal of Neuroscience. 21(23). 9112–9123. 241 indexed citations

Klapstein, Gloria J., Robin S. Fisher, Hadi Zanjani, et al.. (2001). Electrophysiological and Morphological Changes in Striatal Spiny Neurons in R6/2 Huntington's Disease Transgenic Mice. Journal of Neurophysiology. 86(6). 2667–2677. 265 indexed citations

10.

Levine, Michael S., Gloria J. Klapstein, Ahrin Koppel, et al.. (1999). Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. Journal of Neuroscience Research. 58(4). 515–532. 282 indexed citations

11.

Klapstein, Gloria J., B.S. Meldrum, & István Módy. (1999). Decreased sensitivity to Group III mGluR agonists in the lateral perforant path following kindling. Neuropharmacology. 38(7). 927–933. 30 indexed citations

12.

Levine, Michael, Gloria J. Klapstein, Ahrin Koppel, et al.. (1999). Enhanced sensitivity to N‐methyl‐D‐aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. Journal of Neuroscience Research. 58(4). 515–532. 22 indexed citations

13.

Klapstein, Gloria J., David N. Lieberman, Paul A. Gray, et al.. (1998). Calbindin-D28k fails to protect hippocampal neurons against ischemia in spite of its cytoplasmic calcium buffering properties: evidence from calbindin-D28k knockout mice. Neuroscience. 85(2). 361–373. 92 indexed citations

14.

Klapstein, Gloria J. & William F. Colmers. (1997). Neuropeptide Y Suppresses Epileptiform Activity in Rat Hippocampus In Vitro. Journal of Neurophysiology. 78(3). 1651–1661. 142 indexed citations

15.

Klapstein, Gloria J. & William F. Colmers. (1993). On the sites of presynaptic inhibition by neuropeptide y in rat hippocampus in vitro. Hippocampus. 3(1). 103–111. 120 indexed citations

16.

Klapstein, Gloria J. & William F. Colmers. (1992). 4‐Aminopyridine and low Ca²⁺ differentiate presynaptic inhibition mediated by neuropeptide Y, baclofen and 2‐chloroadenosine in rat hippocampal CA1 in vitro. British Journal of Pharmacology. 105(2). 470–474. 55 indexed citations

17.

Colmers, William F., et al.. (1991). Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y₂ receptor. British Journal of Pharmacology. 102(1). 41–44. 160 indexed citations

18.

Klapstein, Gloria J., et al.. (1990). Neuropeptide Y Presynaptic Effects in Hippocampal Slice In Vitro Are Y₂ Receptor Mediated but Not via Inhibition of Adenylate Cyclasea. Annals of the New York Academy of Sciences. 611(1). 457–458. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact